NSD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.301600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.471600E-01
Normal-vs-Stage2
3.028500E-02
Normal-vs-Stage3
8.552400E-02
Normal-vs-Stage4
4.205600E-01
Stage1-vs-Stage2
1.626020E-01
Stage1-vs-Stage3
9.383300E-03
Stage1-vs-Stage4
7.053200E-01
Stage2-vs-Stage3
8.16930000000493E-05
Stage2-vs-Stage4
6.062200E-01
Stage3-vs-Stage4
2.509000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.306400E-02
Normal-vs-AfricanAmerican
1.935560E-01
Normal-vs-Asian
5.632500E-02
Caucasian-vs-AfricanAmerican
5.946200E-01
Caucasian-vs-Asian
3.647200E-01
AfricanAmerican-vs-Asian
3.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.300200E-02
Normal-vs-Female
3.128500E-02
Male-vs-Female
9.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.686400E-01
Normal-vs-Age(41-60Yrs)
1.138570E-01
Normal-vs-Age(61-80Yrs)
2.049500E-02
Normal-vs-Age(81-100Yrs)
1.198150E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.903000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.306800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.387020E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.484900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.323960E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.307600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.106100E-02
Normal-vs-Daily Drinker
9.920800E-03
Normal-vs-Weekly Drinker
2.066300E-02
Normal-vs-Occasional Drinker
4.889700E-02
Normal-vs-Social Drinker
1.774350E-01
Non Drinker-vs-Daily Drinker
9.599200E-01
Non Drinker-vs-Weekly Drinker
9.941800E-01
Non Drinker-vs-Occasional Drinker
2.767000E-01
Non Drinker-vs-Social Drinker
2.697500E-02
Daily Drinker-vs-Weekly Drinker
9.719600E-01
Daily Drinker-vs-Occasional Drinker
2.702400E-01
Daily Drinker-vs-Social Drinker
2.810400E-02
Weekly Drinker-vs-Occasional Drinker
3.519000E-01
Weekly Drinker-vs-Social Drinker
5.747700E-02
Occasional Drinker-vs-Social Drinker
2.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.835500E-02
Normal-vs-Grade 2
2.354500E-02
Normal-vs-Grade 3
1.620470E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.774400E-01
Grade 1-vs-Grade 3
4.605600E-01
Grade 1-vs-Grade 4
8.835500E-02
Grade 2-vs-Grade 3
2.971200E-01
Grade 2-vs-Grade 4
2.354500E-02
Grade 3-vs-Grade 4
1.620470E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.542800E-03
Normal-vs-NonDiabetic
1.378360E-02
Diabetic-vs-NonDiabetic
3.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.649600E-02
Normal-vs-NoPancreatitis
1.241680E-02
Pancreatitis-vs-NoPancreatitis
5.146400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.504000E-02
Normal-vs-N1
3.045800E-02
N0-vs-N1
8.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.243900E-02
Normal-vs-TP53-NonMutant
2.573200E-01
TP53-Mutant-vs-TP53-NonMutant
1.835390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
